All In MedTech

Device Trial Radar · NCT06315023

The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

Prospective, Single Arm, Registry-based Study to Evaluate the Real-world Use of the DETOUR™ System in US Patients

Last checked: Nov 20, 2026Latest source record: May 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

450

Planned (sponsor's estimate)

Start

Oct 6, 2023

Primary completion

Jun 7, 2028

Study completion Jun 7, 2032

Sponsor

Lead sponsor
EndologixNot on our public-company list
Sponsor type
Industry
Collaborators
Fivos; Massachusetts General Hospital; Society for Vascular Surgery Patient Safety Organization
First posted
Mar 18, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.

Conditions

  • Peripheral Arterial Disease
  • Symptomatic Femoropopliteal Lesions

Interventions

  • DETOUR SystemDevice

    Percutaneous Transmural Arterial Bypass Therapy using the DETOUR™ System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from CD-TLRTime frame: 1 Year
  2. Freedom from MAETime frame: 30 Days

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Salinas Valley Memorial Hospital

    Salinas, California

  • University of Connecticut

    Storrs, Connecticut

  • Medstar Washington Hospital Center

    Washington D.C., District of Columbia

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.